Teva Pharmaceutical Financial Statements Trends

TEVA -- Israel Stock  

ILS 6,018  14.00  0.23%

This module enables investors to look at Teva Pharmaceutical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Operating Income of 2.1 B, Revenues of 18.9 B or Weighted Average Shares of 1 B, but also many exotic indicators such as Interest Coverage of 8.9405, Long Term Debt to Equity of 0.6329 or Calculated Tax Rate of 36.4467. This module is a perfect complement to use when analyzing Teva Pharmaceutical Valuation or Volatility. It can also complement various Teva Pharmaceutical Technical models. Also please take a look at World Market Map.
Revenues

Teva Pharmaceutical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets54.3 B83.6 B55.7 B
Increasing
Slightly volatile
Total Liabilities38.5 B53.6 B31.7 B
Increasing
Slightly volatile
Shareholders Equity25.3 B30 B24.8 B
Increasing
Slightly volatile
Current Assets18.4 B15.3 B14.9 B
Increasing
Slightly volatile
Current Liabilities13 B16.7 B12.8 B
Increasing
Slightly volatile

Teva Pharmaceutical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues18.9 B19.7 B18.4 B
Increasing
Slightly volatile
Net Income(2.4 B)378.4 M1.4 B
Decreasing
Slightly volatile
Weighted Average Shares1 B859.5 M887 M
Increasing
Slightly volatile
Weighted Average Shares Diluted824.3 M864.9 M883 M
Increasing
Very volatile
Operating Income2.1 B1.9 B2.6 B
Decreasing
Stable

Teva Pharmaceutical Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow from Financing13 B22.7 B7 B
Increasing
Slightly volatile
Net Cash Flow from Investing(25.4 B)(41.1 B)(13.5 B)
Decreasing
Slightly volatile
Net Cash Flow from Operations2.5 B4.7 B4.1 B
Increasing
Slightly volatile

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share1.29810.08051.8607
Decreasing
Slightly volatile
Earnings per Diluted Share(2.35)0.08051.53
Decreasing
Slightly volatile
Return on Average Equity(0.1431)1.19917.7013
Decreasing
Slightly volatile
Return on Average Assets0.02820.51423.9983
Decreasing
Slightly volatile
Gross Margin48.319548.728952.9858
Decreasing
Stable
Profit Margin(0.114)1.72749.5453
Decreasing
Slightly volatile
EBITDA Margin18.282613.939918.4561
Decreasing
Slightly volatile
Asset Turnover0.41340.34140.3913
Decreasing
Slightly volatile
Sales per Share19.159220.585220.5132
Increasing
Slightly volatile
Debt to Equity Ratio1830.966515.8097
Increasing
Slightly volatile
Current Ratio0.961.05331.2138
Decreasing
Slightly volatile
Free Cash Flow per Share1.644.06383.6486
Increasing
Stable
Total Assets Per Share65.561982.365560.6923
Increasing
Slightly volatile
Cash Flow Per Share4.3624.6334.6692
Increasing
Slightly volatile
Return on Investment7.4644.55048.1902
Decreasing
Slightly volatile
Operating Margin15.711.309415.4955
Decreasing
Slightly volatile
Calculated Tax Rate36.446756.905324.0419
Increasing
Slightly volatile
Receivables Turnover2.9833.05433.2835
Increasing
Stable
Inventory Turnover1.89172.02682.0008
Increasing
Stable
PPandE Turnover3.79573.4373.415
Decreasing
Slightly volatile
Cash and Equivalents Turnover8.4776.33218.5463
Decreasing
Stable
Accounts Payable Turnover6.09046.83676.1348
Increasing
Slightly volatile
Interest Coverage8.94051.862512.1931
Decreasing
Slightly volatile
Long Term Debt to Equity0.63290.87810.5169
Increasing
Slightly volatile
Quick Ratio0.70410.5280.69
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets3.1679(1.9288)5.2388
Decreasing
Slightly volatile
Revenue to Assets0.36280.27120.3612
Decreasing
Slightly volatile

Teva Pharmaceutical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings Before Interest Taxes and Depreciation Amortization EBITDA4.8 B2.4 B3.3 B
Increasing
Very volatile
Revenue Per Employee362.9 K345.1 K409.8 K
Decreasing
Slightly volatile
Net Income Per Employee30.7 K6.6 K45 K
Decreasing
Slightly volatile

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Teva Pharmaceutical Fundamental Drivers

Teva Pharmaceutical Industries Limited Fundamental Market Drivers

Forward Price Earnings1,867.92
Average Daily Volume Last 10 Day3.04M
Average Daily Volume In Three Month780.41k
Fifty Day Average6,618.27
Two Hundred Day Average7,369.96
Also please take a look at World Market Map. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com